BPC-157: Research Overview and Mechanism

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide corresponding to a partial sequence of a protective protein identified in gastric juice. Its 15-residue length is why it is described as a pentadecapeptide in research literature.

It is a stable peptide used as a tool compound for probing repair-associated pathways in laboratory models, distinct from the larger growth-factor proteins that also participate in tissue repair.

In preclinical models, BPC-157 is studied for its association with angiogenesis (the formation of new blood vessels), cytoprotection, and cellular-repair processes, including in gastrointestinal-model research. Mechanistic work in these models has associated its pro-angiogenic activity with the VEGFR2 signaling pathway and with modulation of the nitric-oxide system, and its cytoprotective activity with growth-factor and focal-adhesion (FAK-paxillin) signaling. This body of work is predominantly preclinical and animal-model literature describing the molecule, not human outcomes.

Because these pathways are complementary to those studied for TB-500, the two peptides are combined in tissue-repair research blends such as Wolverine and GLOW-70.

Pinnacle BPC-157 is supplied as a 5mg lyophilized powder (CAS 137525-51-0) with a lot-matched Certificate of Analysis reporting HPLC purity and mass-spectrometry identity against its roughly 1419.5 g/mol mass. Its C62H98N16O22 sequence contains no cysteine, so unlike copper or disulfide peptides it carries no color or bridge chemistry and reconstitutes to a clear solution. Store the powder at -20C protected from light, and add bacteriostatic water down the vial wall rather than shaking.